OUR PRODUCTS
Credo Diagnostics Biomedical develops point-of-care (POC) diagnostic technology.
Our nucleic acid diagnostic platform is designed to be used by any personnel with minimal training. Our solution covers sample preparation, amplification and detection through simple operating procedures with short turnaround time with no compromise on accuracy and sensitivity.
OUR VISION
We at Credo Diagnostics Biomedical, the pioneers of accessible diagnostic platforms, want to improve the lives of those we love.
We believe providing the right information to the right people at the right time leads to better outcomes.
NEWS
- 2020.10.30 VitaPCR Influenza A&B/SARS-CoV-2 assay Receives CE Mark view more
- 2020.03.17 Credo Diagnostics Biomedical VitaPCR SARS-CoV-2 Assay Garners CE Mark. view more
- 2020.02.21 Credo Diagnostics Biomedical is finalizing a rapid point-of-care molecular test for the detection of novel Coronavirus COVID-19 in 20 minutes view more
CONTACT
We at Credo Diagnostics Biomedical pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.
SUBSCRIBE TO NEWSLETTER
Subscribe to our newsletter to receive latest news on our products and services.